Cost-utility of respiratory syncytial virus prefusion F (RSVpreF) maternal vaccine for disease prevention among colombian infants
Respiratory Syncytial Virus (RSV) is one of the leading causes of acute lower respiratory tract infections in Colombia, therefore, as no widespread antiviral exists, maternal immunization using RSV prefusion F protein vaccine (RSVpreF) represents a promising strategy. This study aims to evaluate the cost-utility...